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Sleep-related brain activation does not increase the
permeability of the blood–brain barrier to glucose
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Vera Ferrari, Carlo Franzini, Pierluigi Lenzi and Giovanna Zoccoli
Dipartimento di Fisiologia Umana e Generale, Università di Bologna, Bologna, Italy
We compared blood–brain barrier (BBB) permeability to glucose between quiet wakefulness and
rapid-eye-movement (REM) sleep to assess whether changes in BBB permeability play a role in
coupling glucose supply to the physiologic metabolic needs of the brain. Male Sprague–Dawley rats
were prepared with electrodes for wake–sleep state scoring and with arterial and venous catheters.
Using the single-pass, dual-label indicator method, unidirectional glucose extraction by the brain
and cerebral blood flow (CBF) were simultaneously measured during states of quiet wakefulness
(n¼ 12) or REM sleep (n¼ 7). The product of BBB surface area and permeability to glucose (PS
product) was computed in each state. During REM sleep, CBF significantly exceeded that during
quiet wakefulness in all regions but the cerebellum, whereas the difference in the PS product
between quiet wakefulness and REM sleep was not statistically significant in any brain region. In the
brain as a whole, CBF significantly increased 29% from quiet wakefulness to REM sleep, while a
nonsignificant 0.8% increase occurred in the PS product. During REM sleep, the increase in CBF
indicates a higher rate of brain glucose consumption than in quiet wakefulness, given the tight flow-
metabolism coupling in the brain. Therefore, these data show that modulation of BBB permeability
to glucose is not a mechanism that provides ‘energy on demand’ during the physiologic brain
activation characterising REM sleep.
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Introduction
The adult brain mainly relies on glucose for its
energy metabolism (Dienel, 2002). In the brain,
carbohydrate stores exist in astrocytes as glycogen,
which is only sufficient to fuel the cerebral rate of
glucose consumption for a limited time (Brown,
2004). The brain therefore depends on a continuous
supply of glucose from the circulation. To be
transported into the brain, blood glucose must cross
the blood–brain barrier (BBB) through stereospecific
GLUT-1 membrane carriers (Duelli and Kuschinsky,
2001). Net blood–brain glucose transport is the
result of two opposite unidirectional glucose fluxes.
The fluxes in each direction depend mainly on the
glucose concentration in the fluid adjacent to the
capillary wall, the surface area (S) of the capillary
network, and the capillary permeability (P) to
glucose, which itself is a function of the density
and kinetic constants of GLUT-1 transporters on the
barrier membranes and of glucose concentration in
the cis-side fluid (Gjedde, 1992). The unidirectional
blood–brain glucose transport is limited in physio-
logic conditions by the diffusion across the BBB
rather than by cerebral blood flow (CBF) (Gjedde,
1992; Lund-Andersen, 1979).
During pharmacologically induced tremors
(Cremer et al, 1983) or seizures (Cornfold et al,
2000), the unidirectional clearance of blood glucose
across the BBB rises acutely (Cornfold et al, 2000;
Cremer et al, 1983), thereby effectively increasing
glucose supply to the brain in times of increased
demand. It has recently been hypothesised that a
raised glutamatergic tone in the cerebral cortex
activates allocation of glucose to the brain by
promoting GLUT1-mediated glucose transport across
the BBB (Peters et al, 2004). Such an effect could be
mediated by increases in GLUT-1 transporter density
on the barrier membranes, conformational changes of
Received 30 November 2004; revised 24 January 2005; accepted
26 January 2005; published online 9 March 2005
Correspondence: Professor G Zoccoli, Dipartimento di Fisiologia
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the GLUT-1 transporters leading to an increased
maximum velocity of transfer and/or to a decreased
half-saturation constant (Gjedde, 1992), increases in
the number of perfused capillaries, and increases in
the homogeneity of perfusion rates in the capillary
network (Kuschinsky and Paulson, 1992). It is still
unclear whether a modulation of one or more of
these variables is involved in maintaining brain
tissue homeostasis in the face of physiologic rather
than extreme increases in brain activity. To address
this question, one must contend with the difficulty
of eliciting a condition of brain activation that is
both physiologic and widespread, while avoiding
the effects of stress (Esposito et al, 2001) or
anaesthesia (Gjedde, 1992; Gjedde and Rasmussen,
1980) on the BBB. Rapid-eye-movement (REM)
sleep is a spontaneous, repetitive, and physiologic
behavioural state, which entails increases in CBF
with respect to quiet wakefulness in human
subjects (cf. Maquet (2000) for a review) and animal
models (Maquet, 2000; Zoccoli et al, 2002). In
rats, in particular, regional CBF increases during
REM sleep with respect to quiet wakefulness
are both substantial and widespread (Zoccoli
et al, 1994).
Thus, we assessed whether the PS product for
blood–brain glucose transport differs between quiet
wakefulness and REM sleep in unrestrained rats 10
days after surgical preparation. The CBF is coupled
to brain metabolism during sleep as well as during
wakefulness (Madsen, 1993). Therefore, if the BBB
takes a part in coupling brain glucose uptake to
physiologic synaptic function (Peters et al, 2004),
BBB permeability to glucose will increase from quiet
wakefulness to REM sleep to provide ‘energy on
demand’ during physiologic brain activation.
Methods
The experiments were performed on 36 male Sprague–
Dawley rats (Charles River, 250–300 g). The study protocol
was approved by the Bologna University ethical commit-
tee on animal experimentation. Animals were kept on a
light–dark schedule of 12/12 h with the light on at
9.00 a.m., ambient temperature controlled at 231C and
free access to food and water.
Surgery
Surgery was performed under general anaesthesia (1%
halothane, 30% O2, balance N2O) and sterile conditions.
Electrodes were implanted for electroencephalographic
and electromyographic recordings. Two Silastic catheters
were positioned in the abdominal aorta and the inferior
vena cava via the femoral artery and vein, respectively.
Catheters were tunnelled subcutaneously and fixed to the
skull, together with the electrodes, by dental acrylic. An
osmotic pump (ALZA 2002, Durect Co., Cupertino, CA,
USA) was implanted subcutaneously to continuously
administer calcium heparin (10 IU/100g day).
Experimental Procedures
After one week’s recovery, each animal was habituated for
three days to the recording apparatus, which consisted of
a Plexiglas cylinder (20 cm in diameter) placed inside
a thermoregulated box. An air-pressure-operated blade
controlled from outside the box was mounted on the
movable lid of the cylinder.
The dual-label indicator-fractionation method (Harik et
al, 1994; Puchowicz et al, 2004; Sage et al, 1981) was
adapted to the study of freely moving animals and used to
simultaneously measure cerebral glucose extraction and
CBF. On the day of the experiment, a polyethylene tube was
filled with 60mL of saline buffered solution (10 mmol/L
HEPES buffer, pH 7.40) containing 4-[N-methyl-14C]
iodoantipyrine (NEN; 0.231 to 0.482 MBq, 1.96 GBq/mmol),
D-[2-3H] glucose (NEN; 0.794 to 1.208 MBq, 740.0 GBq/
mmol), and 10 mmol/L nonradioactive glucose. Purity of
the radioactive material added to the solution was assessed
by paper or silica gel chromatography. The polyethylene
tube was connected on one side to the venous catheter and
on the other to a 250mL Hamilton syringe. The arterial
catheter was connected to two polyethylene tubes by means
of a T-shaped connector. Through one of these tubes (20mL
in volume), an arterial blood sample (150mL) was obtained
during the wake–sleep state chosen for the experiment and
analysed (Gem 3000, Instrumentation Laboratory, Italy) at a
reference temperature of 371C. The other tube was con-
nected to a syringe fitted in a Sage pump (Cambridge, MA,
USA) calibrated to withdraw blood at a rate of 1.5 mL/min.
The wake–sleep state was scored according to poly-
graphic and behavioural criteria: in particular, electro-
encephalographic theta rhythm of higher amplitude,
muscle atonia, and twitches distinguish REM sleep from
quiet wakefulness. Measurements in quiet wakefulness
were taken after spontaneous awakenings from sleep, the
rat lying still. During stable states of quiet wakefulness
(n¼ 12) or REM sleep (n¼ 7), the withdrawal pump was
started and saline injected (100 mL, 4 secs) through the
Hamilton syringe, flushing the radioactive solution in the
polyethylene tube into the inferior vena cava. In REM
sleep, injection started 50718 secs after the beginning of a
stable REM sleep state. At a fixed time interval after the
beginning of the injection, determined in preliminary
experiments as 13 secs (see Results), the rat was decapi-
tated by means of the air-pressure-operated blade and the
withdrawal pump stopped simultaneously. All animals
maintained a stable behavioural state (i.e., did not fall
asleep from quiet wakefulness or awake from REM sleep)
during the circulation time of the radioactive bolus
through the cerebral circulation.
Three samples (5mL each) of the prevalently venous
blood that dripped from the foramen magnum were
collected to estimate radioactivity (liquid b-scintillator,
LS 6500, Beckman, Fullerton, CA, USA) in the cerebral
intravascular space (Harik et al, 1994; Puchowicz et al,
2004). Aliquots of the withdrawn arterial blood were taken
for radioactivity measurement. The brain was rapidly
removed and dissected into medulla, pons, midbrain,
cerebellum, diencephalon, hippocampi, and cerebral
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hemispheres. Samples were weighed and sonicated in
distilled water before radioactivity measurement.
Optimal Cerebral Perfusion Time
To determine the optimal time from injection to decapita-
tion, that is, the shortest time allowing most of the
radioactive bolus to pass through cerebral capillaries,
preliminary experiments were performed in a separate
group of rats (n¼ 8) according to the method described by
Sage et al (1981). Rats were prepared under general
anaesthesia with arterial and venous catheters, as pre-
viously described. Two rats were implanted with an
additional catheter in the confluence of the cerebral
sinuses. A bolus containing L-[1-3H(N)] glucose (NEN;
0.968 to 1.079 MBq, 540.2 GBq/mmol) was adminis-
tered with identical injection parameters as used in
D-glucose experiments. L-glucose was chosen because
of its limited capacity to cross the BBB. Serial blood
samples consisted of blood drops freely dripping from
the arterial and cerebral venous catheters and
singly collected in preweighed vials. The times of
collection for each drop from the start of the injection
were measured.
Apparent Cerebral Volume of Distribution of L-glucose
To accurately estimate carrier-mediated D-glucose trans-
port across the BBB, the contributions because of simple
diffusion, vesicular transport (Lucchesi and Gosselin,
1990), and residual intravascular label were estimated by
measuring the apparent volume of distribution of
L-glucose (Harik et al, 1994; Puchowicz et al, 2004) under
the same protocol used in D-glucose experiments.
L-[1-3H(N)] glucose (NEN; 0.902 to 1.062 MBq,
540.2 GBq/mmol) was injected during quiet wakefulness
(n¼ 6) or REM sleep (n¼ 3). The apparent volume of
distribution of L-glucose in each region was computed as
the ratio of [3H]L-glucose radioactivity in each brain region
and the plasmatic [3H]L-glucose concentration in the
blood obtained from the foramen magnum.
Data Analysis
Regional CBF (mL/100 g min) was calculated as (Harik
et al, 1994; Puchowicz et al, 2004; Sage et al, 1981):
CBF ¼ ð100FS½14CBÞ=ð½
14CSWÞ ð1Þ
where FS is the withdrawal rate of the pump, W is the
weight of the brain sample, and [14C]B and [
14C]S indicate
the [14C]iodoantipyrine radioactivity in the brain sample
and in the arterial blood, respectively. Equation (1)
assumes high permeability for iodoantipyrine (i.e., that
iodoantipyrine flux across the BBB is limited by blood
flow) and that no iodoantipyrine backflux occurs from
brain to blood during the measurement. The first assump-
tion is substantially verified when CBF is lower than
180 mL/100 g min (van Uitert et al, 1981). The backflux
error is proportional to CBF and the duration of the
experiment and is inversely proportional to the brain–
blood partition coefficient for the indicator.






where [3H]B and [
3H]S indicate the [
3H]D-glucose radio-
activity in the brain sample and in the arterial blood,
respectively. Equation (2) assumes that no backflux of
[3H]D-glucose occurs from brain to blood during the
measurement. The backflux error has the same depen-
dency as that of Equation (1).
In each experiment, the regional apparent volume of
distribution of L-glucose was multiplied by the plasmatic
radioactivity of [3H]D-glucose in the blood obtained from
the foramen magnum. For each region, this product was
then subtracted from [3H]B to correct for the contribution
due to noncarrier-mediated glucose transport and
residual intravascular [3H] (Harik et al, 1994; Puchowicz
et al, 2004).
Regional permeability-surface area (PS) product was
computed from E and cerebral plasma flow
(CPF¼CBF(1hematocrit)) according to the equation
(Crone, 1965):
PS ¼ CPF lnð1  EÞ ð3Þ
where ln indicates natural logarithm. Equation (3)
assumes that E represents unidirectional blood-to-brain
glucose extraction, and propagates any error in CBF and E
resulting from the violation of the assumptions of
equations (1) and (2).
Data for brain regions and for the whole brain are
expressed as mean values7s.d., with n indicating the
number of animals. Values of CBF, E, and PS presented
for the brain as a whole were computed on the basis of
the sum, for each animal, of the respective weight, [3H]-
radioactivity, and [14C]-radioactivity of the regional
samples in which the whole brain was dissected.
Statistical significance of the differences between quiet
wakefulness and REM sleep for each brain region was
assessed by Student’s t-test with a comparison-wise error
rate (Kusuoka and Hoffman, 2002) of Po0.05.
Results
Analysis of Arterial Blood
Results of the arterial blood analysis are reported in
Table 1. Results were similar to those previously
obtained in healthy rats (Zoccoli et al, 1994, 1996)
and did not differ significantly between quiet
wakefulness and REM sleep.
Optimal Cerebral Perfusion Time
Results of a representative experiment are reported
in Figure 1. In this experiment, the recirculation
time of the radioactive bolus was also apparent. The
peak concentration of [3H]L-glucose in the cerebral
venous blood occurred 4 secs after the peak of
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arterial concentration. Cerebral venous concentra-
tion of [3H]L-glucose then decreased sharply to 44%
of the peak venous radioactivity 11 secs after the
start of injection, to decrease more slowly after-
wards. A secondary peak in arterial concentration
due to recirculation of the radioactive bolus
occurred 15 secs after the start of injection. The
optimal decapitation time was selected as 13 secs
after the start of injection, that is, half-way between
the onset of the slow decrease in cerebral venous
radioactivity and the arterial recirculation peak.
Blood pressure was not measured during the
experiment; however, the paucity of the blood loss
due to sampling (220 mL after 20 secs in the experi-
ment in Figure 1) makes it unlikely that major
changes in blood pressure biased the result.
Apparent Cerebral Volume of Distribution of L-glucose
In one rat, in quiet wakefulness, the values of the
apparent volume of distribution of L-glucose in
the medulla and pons exceeded the meanþ 2s.d. of
the values in the corresponding region and were
thus excluded from the subsequent analysis.
The apparent volume of distribution of L-glucose
for each brain region did not significantly differ
between quiet wakefulness and REM sleep, in
agreement with the paucity of changes in cerebral
blood volume between quiet wakefulness and REM
sleep (Risberg and Ingvar, 1973), and with the lack of
brain capillary recruitment between these states
(Zoccoli et al, 1996). Data for each region were
therefore pooled between states and are reported in
Figure 2.
Regional Cerebral Blood Flow, Glucose Extraction
Fraction, and Permeability–Surface Area Product for
Glucose
Regional CBF data in quiet wakefulness and in REM
sleep are reported in Figure 3. Regional CBF in REM
sleep significantly exceeded that in quiet wakefulness
Table 1 Results of the arterial blood gas analysis in quiet
wakefulness and REM sleep
Quiet wakefulness REM sleep
PaO2 (mm Hg) 91.074.1 87.176.1
PaCO2 (mm Hg) 39.471.8 40.472.8
pH 7.4570.02 7.4570.04
Hct (%) 3774 3875
Glucose (mmol/L) 6.770.6 6.870.5
Lactate (mmol/L) 1.270.5 0.970.3
Sodium (mmol/L) 141.372.6 139.371.8
Data are mean values7s.d. PaO2 and PaCO2, arterial tension of oxygen and
carbon dioxide, respectively; Hct, hematocrit; REM, rapid-eye-movement.
Results did not differ significantly between states.






















Figure 1 Optimal cerebral perfusion time. Arterial (dashed line)
and cerebral venous (continuous line) radioactivity of labelled
L-glucose after intravenous injection in a representative experi-
ment. Both arterial and venous radioactivity are reported as
percentages of the respective peak value.


























Figure 2 Apparent cerebral volume of distribution of L-glucose.
Volume of distribution of L-glucose in the cerebral regions
examined under the same setting adopted in the D-glucose
experiments. Mean values and s.d. of the data pooled between
quiet wakefulness and rapid-eye-movement (REM) sleep are
reported (n¼9). MED, medulla; CBL, cerebellum; MDB,
midbrain; DIE, diencephalon; HIP, hippocampi; HEM, cerebral
hemispheres. Values in hippocampi and cerebral hemispheres
are mean values over left and right samples.



























Figure 3 Regional cerebral blood flow in quiet wakefulness and
in rapid-eye-movement (REM) sleep. Blood flow in the cerebral
regions examined in quiet wakefulness (white bars, n¼12) and
REM sleep (black bars, n¼7). Mean values and s.d. of the data
are reported for each region. MED, medulla; CBL, cerebellum;
MDB, midbrain; DIE, diencephalon; HIP, hippocampi; HEM,
cerebral hemispheres. Values in hippocampi and cerebral
hemispheres are mean values over left and right samples.
*Po0.05 versus quiet wakefulness.
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by approximately 30% in all regions but the cere-
bellum. In the brain as a whole, CBF was 107.17
16.7 mL/100 g min in REM sleep and 83.1714.6 mL/
100 g min in quiet wakefulness, the difference being
statistically significant.
Conversely, glucose extraction fraction in the
different brain regions was lower in REM sleep than
in quiet wakefulness, the difference being signifi-
cant in the mesencephalon, diencephalon, hippo-
campi, and cerebral hemispheres (Figure 4). In the
brain as a whole, glucose extraction fraction was
0.2170.04 in REM sleep and 0.2570.03 in quiet
wakefulness, the difference being statistically sig-
nificant.
As a result of the contrasting increases in CBF and
decreases in glucose extraction fraction, the differ-
ence in the PS product between quiet wakefulness
and REM sleep was not statistically significant in
any brain region, P ranging from 0.23 to 0.89 in the
different regions. Regional PS product for glucose
during quiet wakefulness and REM sleep is reported
in Figure 5. In the brain as a whole, PS product for
glucose was 15.272.8 mL/100 g min in REM sleep
and 15.172.4 mL/100 g min in quiet wakefulness.
The difference between states was less than 1% of
the value in quiet wakefulness and was not
statistically significant (P¼ 0.93).
Discussion
We simultaneously measured the PS product for
blood–brain glucose transport and CBF in unrest-
rained rats during spontaneous states of quiet
wakefulness and REM sleep. In REM sleep, no
significant change in BBB permeability to glucose
occurred with respect to quiet wakefulness in
spite of a substantial widespread increase in CBF.
This finding indicates that modulation of BBB
permeability is not involved in providing
glucose ‘on demand’ during physiologic brain
activation.
The adult brain mainly relies on blood-borne
glucose for its energy metabolism (Dienel, 2002). It
has recently been hypothesised that facilitation of
glucose diffusion across the BBB via GLUT-1
transporters is a physiologic mechanism that
couples synaptic function with brain glucose uptake
(Peters et al, 2004). This hypothesis has never been
directly proved. To resolve the issue, we adapted
the dual-label indicator fractionation technique
(Harik et al, 1994; Puchowicz et al, 2004; Sage
et al, 1981) to directly measure the PS product for
blood–brain glucose transport in physiologic condi-
tions of quiet wakefulness and REM sleep.
Rapid-eye-movement sleep is a physiologic and
repetitive behavioural state in which high cerebral
energy requirements correspond to a sustained
neuronal activity (Maquet, 2000). In our experimen-
tal conditions, during REM sleep, CBF significantly
increased with respect to quiet wakefulness in all
cerebral regions examined but the cerebellum
(Figure 3). The CBF increases agree with previous
measurements obtained in our laboratory using
radioactive microspheres (Zoccoli et al, 1994), a
technique independent from the assumptions of the
indicator-fractionation method applied in the pre-
sent study. Changes in CBF across wake–sleep states
are because of variations in cerebral vascular
resistance rather than arterial pressure (Zoccoli
et al, 2002), and the flow-metabolism coupling
is effective in the brain during sleep and during
wakefulness (Madsen, 1993). Therefore, the in-
creases in CBF during REM sleep suggest that the
cerebral metabolic rate of glucose consumption was
higher in this state. In agreement with this view,























* * * *
Figure 4 Regional cerebral extraction fraction of glucose in
quiet wakefulness and in rapid-eye-movement (REM) sleep.
Glucose extraction fraction in the cerebral regions examined in
quiet wakefulness (white bars, n¼12) and REM sleep (black
bars, n¼7). Mean values and s.d. of the data are reported for
each region. MED, medulla; CBL, cerebellum; MDB, midbrain;
DIE, diencephalon; HIP, hippocampi; HEM, cerebral hemi-
spheres. Values in hippocampi and cerebral hemispheres are
mean values over left and right samples. *Po0.05 versus REM
sleep.



























Figure 5 Regional cerebral permeability–surface area (PS)
product for glucose during quiet wakefulness and rapid-eye-
movement (REM) sleep. PS product for blood–brain glucose
transport in the cerebral regions examined in quiet wakefulness
(white bars, n¼12) and REM sleep (black bars, n¼7). Mean
values and s.d. of the data are reported for each region. MED,
medulla; CBL, cerebellum; MDB, midbrain; DIE, diencephalon;
HIP, hippocampi; HEM, cerebral hemispheres. Values in
hippocampi and cerebral hemispheres are mean values over
left and right samples. No significant difference was found
between states in any region.
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both CBF and the cerebral metabolic rate of glucose
consumption rise at a regional level during REM
sleep in human subjects (Maquet, 2000). Therefore,
REM sleep may be regarded as a state of physiologic
brain activation, which was remarkably widespread
in the rat model we studied.
The wide increase in CBF observed from quiet
wakefulness to REM sleep was accompanied by a
reduction in the cerebral extraction fraction of
glucose, which was statistically significant in
mesencephalic, diencephalic, and telencephalic
regions (Figure 4); as a result, regional PS product
for blood–brain glucose transport did not signifi-
cantly differ between states. Large values of glucose
extraction fraction and PS product were computed
in the medulla in one rat in REM sleep and in the
pons in a different rat in REM sleep. A greater
variability in glucose extraction and PS values in the
brainstem may be ascribed to the difficulty of
removing pial membranes when dissecting tissue
samples from this brain region (Lucchesi and
Gosselin, 1990). Accordingly, the only outlier values
of the volume of distribution of L-glucose were
obtained in the brainstem (see Results). In all other
regions, differences of the mean PS product between
states were negligible and both increases and
decreases in the mean PS product were observed
in the different regions (Figure 5). The indicator-
fractionation method that we and others (Cornfold
et al, 2000; Harik et al, 1994; Puchowicz et al,
2004; Sage et al, 1981) adopted is based on
assumptions (see Methods) that are violated, albeit
modestly, in its experimental application, yielding
an underestimation of CBF, E, and PS. Tracer
backflux depends inversely on the brain–blood
partition coefficient of the tracer. The partition
coefficient of [3H]D-glucose, estimated from that of
3-O-methylglucose, is lower than 0.55 mL/g (Namba
et al, 1987), and is thus lower than the partition
coefficient of [14C]iodoantipyrine, which is 0.80 mL/
g (Sakurada et al, 1978). Because the errors due to
tracer backflux depend directly on CBF, the under-
estimation of CBF, E, and PS in our study was more
marked in REM sleep than in quiet wakefulness.
However, the dependence of the backflux error on
CBF is stronger for [14C]iodoantipyrine, whose
transport across the BBB is limited by blood flow,
than for [3H]D-glucose, whose transport is substan-
tially diffusion-limited. Moreover, even with wide
changes in CBF from 50 to 250 ml/100 g min and
after 15 secs, only a 2% decrease occurs in the
apparent brain extraction of butanol (Sage et al,
1981), whose transport is flow-limited and whose
partition coefficient of 0.77 mL/g (Gjedde et al, 1980)
is slightly lower than that of iodoantipyrine. Thus,
available evidence indicates that the errors due to
tracer backflux are small and insufficient to explain
our findings, and it is safe to conclude that
differences in the PS product for blood–brain
glucose transport between quiet wakefulness and
REM sleep were truly negligible in our study.
Because the fraction of cerebral capillaries perfused
by plasma is close to unity and is constant among
wake–sleep states in the same model as in the
present study (Zoccoli et al, 1996), these data
indicate that changes in BBB permeability to glucose
are negligible during sleep-related brain activation.
The unidirectional blood–brain glucose transport is
diffusion-limited in physiologic conditions (Gjedde,
1992; Lund-Andersen, 1979). Therefore, our data
suggest that extracellular glucose in the brain is
continuously consumed and is not at a steady state
during REM sleep. It is unlikely, however, that a
compensatory increase in the PS product would
have occurred in REM sleep after our measurements,
because the extracellular glucose concentration
90 secs after the onset of REM sleep episodes is still
11.4% lower in the rat somatosensory cortex with
respect to wakefulness (Netchiporouk et al, 2001).
Our results are at variance with the increase in the
PS product for blood–brain glucose transport that
occurs when brain activation is induced pharmaco-
logically in rats (Cornfold et al, 2000; Cremer et al,
1983). Such rapid increases in the PS product,
taking less than 3 mins to occur (Cornfold et al,
2000), cannot be ascribed to increases in the surface
area of brain capillaries because capillary recruit-
ment does not occur in the brain (Kuschinsky and
Paulson, 1992; Zoccoli et al, 1996). Rather, the
increase in the measured PS product may be because
of the homogenization of the perfusion rate of
different capillaries within the vascular bed
(Kuschinsky and Paulson, 1992), a redistribution
of carriers among endothelial cell compartments
(Cornfold et al, 2000; Duelli and Kuschinsky, 2001),
or changes in glucose carrier kinetics (Carruthers,
1990; Cornfold et al, 2000). Rapid changes in
glucose carrier kinetics have been described because
of the interaction with barbiturates (Haspel et al,
1999) and lead to a decrease in glucose transfer
across the BBB in vivo (Gjedde and Rasmussen,
1980). Moreover, an aspecific increase in BBB
permeability because of stress may increase the
measured PS product for blood–brain glucose trans-
port in nonphysiologic conditions such as intoxica-
tion (Cremer et al, 1983) or seizures (Cornfold et al,
2000), at least in the diencephalon and cerebellum
(Esposito et al, 2001). During nonphysiologic brain
activation, the increases in BBB permeability to
glucose are accompanied by increases in CBF with
respect to baseline values that are greater (range þ 47%
to þ 239%, cismethrin-induced tremors (Cremer
et al, 1983); þ 50%, seizures (Cornfold et al, 2000))
than those we observed from quiet wakefulness to
REM sleep (range þ 24% to þ 34% in the different
regions). A threshold level for the rise in CBF may be
needed to reduce the heterogeneity of capillary flow
velocities substantially enough to raise the mea-
sured PS product for blood–brain glucose transport.
In addition, the increase in cerebral metabolic needs
during nonphysiologic brain activation may be
higher than the physiologic increase from quiet
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wakefulness to REM sleep, although a direct
comparison is hindered by alterations in the flow-
metabolism coupling in nonphysiologic condi-
tions (Cremer et al, 1983). It is noteworthy that
after the oxidative machinery has reached satura-
tion, glucose consumption increases 15-fold for
each molecule of ATP produced (cf. Lenzi et al,
1999). A threshold level for the cerebral rate of
glucose consumption might thus be required to
trigger a compensatory change in glucose carrier
kinetics or intracellular distribution. Our study
then indicates that such thresholds are hardly
reached in physiological conditions because the
increases in regional CBF observed from quiet
wakefulness to REM sleep compare favourably
with those elicited by functional brain activation
obtained by means of electrical forepaw stimulation
(Ances et al, 2001).
The lack of a compensatory increase in BBB
permeability to glucose during physiologic brain
activation implies that other mechanisms provide
for physiologic increases in the brain requirement
for glucose. The estimated unidirectional glucose
transport to the brain is higher than net glucose
transport, that is, cerebral glucose consumption at
the steady state (Gjedde, 1992; Lund-Andersen,
1979), and the decrease in brain glucose con-
centration tends to equalise net and unidirectional
blood–brain glucose transport, that is, it reduces
glucose backflux from the brain. Moreover, the
affinity for glucose of hexokinase, the first enzyme
involved in glucose metabolism, is high with
respect to glucose concentration in the brain
(Lund-Andersen, 1979). The coupling between
CBF and neuronal activity, although likely linked
to the local brain requirement for oxygen (Lenzi
et al, 1999) rather than to glucose supply to the
brain (Powers et al, 1996), leads to a modest increase
in unidirectional blood–brain glucose transport
during physiologic brain activation. Finally,
although glycogen stores in the brain are too small
to provide for long-term energy requirements, the
breakdown of brain glycogen constitutes an ‘energy
buffer’ that provides for short-term energy needs
(Brown, 2004).
In conclusion, our study shows that BBB perme-
ability to glucose is not modulated to maintain the
homeostasis of the brain’s internal environment
during physiologic brain activation. Thus, the brain
may prioritise its glucose supply by modulating
glucose transporters on the BBB (Peters et al, 2004)
only in times of extreme and nonphysiologic
increases in synaptic activity (Cornfold et al, 2000;
Cremer et al, 1983).
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